BioDrugs impact factor, indexing, ranking (2024)


BioDrugs

Aim and Scope

The BioDrugs is a research journal that publishes research related to Biochemistry, Genetics and Molecular Biology; Medicine; Pharmacology, Toxicology and Pharmaceutics. This journal is published by the Adis International Ltd. The ISSN of this journal is 11738804, 1179190X. Based on the Scopus data, the SCImago Journal Rank (SJR) of BioDrugs is 1.646.

Also, please check the following important details about BioDrugs: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.

According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.

BioDrugs Ranking

Impact Factor: 7.744
Total Citations: 3113
SJR (SCImago Journal Rank): 1.646
Quartile: Q1

The Impact Factor of BioDrugs is 7.744.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times its articles are cited.

The impact factor was devised by Eugene Garfield, the founder of the Institute for Scientific Information (ISI) in Philadelphia. Impact factors began to be calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR). ISI was acquired by Thomson Scientific & Healthcare in 1992, and became known as Thomson ISI. In 2018, Thomson-Reuters spun off and sold ISI to Onex Corporation and Baring Private Equity Asia. They founded a new corporation, Clarivate, which is now the publisher of the JCR.


Important Metrics

Journal Title: BioDrugs
Publisher: Adis International Ltd
ISSN: 11738804, 1179190X
Type: journal
Journal Scope: Biochemistry, Genetics and Molecular Biology; Medicine; Pharmacology, Toxicology and Pharmaceutics
Country: United Kingdom
H-Index: 76
SJR: 1.646
Quartile: Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)

BioDrugs Indexing

The BioDrugs is indexed in:

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).


BioDrugs Impact Factor 2024

The latest impact factor of BioDrugs is 7.744.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times it's articles are cited.

Note: Every year, The Clarivate releases the Journal Citation Report (JCR). The JCR provides information about academic journals including impact factor. The latest JCR was released in June, 2023. The JCR 2024 will be released in the June 2024.


BioDrugs Quartile

The latest Quartile of BioDrugs is Q1.

Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.



Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in BioDrugs?

If your research is related to Biochemistry, Genetics and Molecular Biology; Medicine; Pharmacology, Toxicology and Pharmaceutics, then visit the official website of BioDrugs and send your manuscript.

Tips for publishing in BioDrugs:

Acceptance Rate

Acceptance rate is the ratio of the number of articles submitted to the number of articles published. Researchers can check the acceptance rate on the journal website. Alternatively, they can contact the editor of the journal.

Journal Publication Time

The publication time may vary depending on factors such as the complexity of the research and the current workload of the editorial team. Journals typically request reviewers to submit their reviews within 3-4 weeks. However, some journals lack mechanisms to enforce this deadline, making it difficult to predict the duration of the peer review process.

The review time also depends upon the quality of the research paper.


Final Summary

  • The impact factor of BioDrugs is 7.744.
  • The BioDrugs is a reputed research journal.
  • It is published by Adis International Ltd.
  • The journal is indexed in UGC CARE, Scopus, SCIE.
  • The (SJR) SCImago Journal Rank is 1.646.

Sources: BioDrugs







Similiar Journals


CHEMICO-BIOLOGICAL INTERACTIONS
ISSN: 0009-2797
Publisher: ELSEVIER IRELAND LTD

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY
ISSN: 1742-5255
Publisher: TAYLOR & FRANCIS LTD

DNA AND CELL BIOLOGY
ISSN: 1044-5498
Publisher: MARY ANN LIEBERT, INC

JOURNAL OF MOLECULAR EVOLUTION
ISSN: 0022-2844
Publisher: SPRINGER

MOLECULAR BIOLOGY AND EVOLUTION
ISSN: 0737-4038
Publisher: OXFORD UNIV PRESS

MOLECULAR PHYLOGENETICS AND EVOLUTION
ISSN: 1055-7903
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCE

ONCOGENE
ISSN: 0950-9232
Publisher: SPRINGERNATURE

MOLECULAR REPRODUCTION AND DEVELOPMENT
ISSN: 1040-452X
Publisher: WILEY

GENE THERAPY
ISSN: 0969-7128
Publisher: SPRINGERNATURE

COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY
ISSN: 1532-0456
Publisher: ELSEVIER SCIENCE INC

Top 20 Journals

Credit and Source: Scopus, Clarivate, UGC CARE.